Candriam Equities L Oncology Impact R-H/ LU1864483083 /
| NAV2024-06-06 | Chg.+0.6500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 194.0700EUR | +0.34% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-06-09 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-06-03 | Prospectus | 2024 | English | 3,663.84 KB |
| 2024-06-03 | Prospectus | 2024 | German | 5,520.88 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | English | 262.79 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 269.99 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-07-02 | Key Investor Information | 2022 | English | 296.69 KB |
| 2022-07-02 | Key Investor Information | 2022 | German | 363.84 KB |
